Close

Canaccord Genuity Downgrades Fibrocell Science (FCSC) to Hold Following Acquisition Sep 16, 2019 07:51AM
Fibrocell Science (FCSC) to be Acquired by Castle Creek Pharma for $3/Share Sep 12, 2019 05:42PM
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell Sep 12, 2019 05:40PM
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell Sep 12, 2019 05:40PM
Fibrocell Science (FCSC) Agrees to Be Acquired by Castle Creek for $3/Share Sep 12, 2019 05:34PM


Apr 15, 2019 06:32AM Fibrocell Science (FCSC) Announces Pact with Castle Creek Pharma to Develop and Commercialize FCX-007 Gene Therapy
Apr 15, 2019 06:30AM Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
Apr 15, 2019 06:30AM Fibrocell Announces Collaboration with Castle Creek Pharmaceuticals to Develop and Commercialize FCX-007 Gene Therapy
Aug 9, 2018 08:00AM Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
Aug 9, 2018 08:00AM Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
May 10, 2018 08:00AM Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights
May 10, 2018 08:00AM Fibrocell Reports First Quarter 2018 Financial Results and Recent Highlights
Apr 18, 2018 08:29AM Fibrocell Announces Review of Strategic Alternatives
Apr 18, 2018 08:01AM Fibrocell Science (FCSC) to Review Strategic Alternatives
Apr 18, 2018 08:00AM Fibrocell Announces Review of Strategic Alternatives
Apr 18, 2018 08:00AM Fibrocell Announces Review of Strategic Alternatives
Sep 12, 2017 08:01AM Fibrocell Science (FCSC): Raising PT to $7 Ahead of RDEB Ph1 Results - Canaccord
Aug 3, 2017 08:00AM Fibrocell to Present at Canaccord Genuity 37th Annual Growth Conference